Cutler Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-100
| Closed | – | – | 2764 |
|
|
2021
Q4 | $0 | Sell |
100
-1,700
| -94% | – | ﹤0.01% | 2828 |
|
|
2021
Q3 | $7K | Hold |
1,800
| – | – | ﹤0.01% | 1804 |
|
|
2021
Q2 | $9K | Hold |
1,800
| – | – | ﹤0.01% | 1750 |
|
|
2021
Q1 | $8K | Sell |
1,800
-2,040
| -53% | -$9.07K | ﹤0.01% | 1694 |
|
|
2020
Q4 | $12K | Hold |
3,840
| – | – | ﹤0.01% | 1422 |
|
|
2020
Q3 | $12K | Buy |
3,840
+740
| +24% | +$2.31K | ﹤0.01% | 1272 |
|
|
2020
Q2 | $10K | Hold |
3,100
| – | – | ﹤0.01% | 1231 |
|
|
2020
Q1 | $11K | Sell |
3,100
-1,700
| -35% | -$6.03K | ﹤0.01% | 1116 |
|
|
2019
Q4 | $28K | Buy |
4,800
+1,800
| +60% | +$10.5K | ﹤0.01% | 1057 |
|
|
2019
Q3 | $22K | Sell |
3,000
-3,700
| -55% | -$27.1K | ﹤0.01% | 1038 |
|
|
2019
Q2 | $90K | Buy |
6,700
+2,100
| +46% | +$28.2K | 0.01% | 726 |
|
|
2019
Q1 | $24K | Sell |
4,600
-4,561
| -50% | -$23.8K | ﹤0.01% | 1015 |
|
|
2018
Q4 | $27K | Sell |
9,161
-11,661
| -56% | -$34.4K | ﹤0.01% | 1011 |
|
|
2018
Q3 | $186K | Buy |
20,822
+9,961
| +92% | +$89K | 0.01% | 581 |
|
|
2018
Q2 | $105K | Sell |
10,861
-1,346
| -11% | -$13K | 0.01% | 686 |
|
|
2018
Q1 | $106K | Buy |
12,207
+6,807
| +126% | +$59.1K | 0.01% | 707 |
|
|
2017
Q4 | $67K | Buy |
5,400
+1,000
| +23% | +$12.4K | ﹤0.01% | 1000 |
|
|
2017
Q3 | $36K | Sell |
4,400
-1,538
| -26% | -$12.6K | ﹤0.01% | 1417 |
|
|
2017
Q2 | $100K | Buy |
+5,938
| New | +$100K | ﹤0.01% | 1187 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | -$3K | – | 3505 |
|
|
2016
Q4 | $3K | Buy |
200
+100
| +100% | +$1.5K | ﹤0.01% | 2611 |
|
|
2016
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 2653 |
|